The Latest Breaking News from DEA

The Trials And Tribulations Of Psychedelic Research

This article by Natasha Sumner was originally published on Microdose and appears here with permission.

Benzinga · May 20, 2022

DEA-Endorsed Cannabis Grower Makes History As First 'Plant-Touching' Firm On NASDAQ, Shares Soared

Bright Green Corporation (NASDAQ: BGXX), one of the very few companies selected by the US government to grow, manufacture and sell cannabis and cannabis-related research products, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S.

Benzinga · May 17, 2022

Federal indictment tossed after ex-DEA supervisor says Latinos ‘typically’ supply drugs in Chicago

The unusual move came more than a month after the testimony of Keith Billiot, now retired, a former supervisory special agent for the DEA. He later walked back his comment, telling a judge race was “irrelevant” to the DEA’s work.

Chicago Sun-Times · May 17, 2022

End of COVID-19 emergency endangers substance use treatment - Roll Call

The end of the pandemic may make it harder for vulnerable populations to have access to medication-assisted treatment for drug addiction.

Roll Call · May 10, 2022

Activists Protest At DEA HQ, Demand Legal Access To Psychedelics For Terminally Ill Patients

Activists held a protest, including a die-in outside of the Drug Enforcement Administration (DEA) headquarters in Virginia.

Benzinga · May 9, 2022

Plot twist: Crime novelist Winslow retires from writing to take up political activism

SAN DIEGO — In Don Winslow's crime novels, characters regularly face dangers they should have seen coming. Those who ignore the warning signs often wind up dead.

Tribune News Service · May 8, 2022

Marijuana Trafficking Is Changing At US-Mexico Border — Here's How

This article was originally published on The Fresh Toast and appears here with permission.

Benzinga · May 6, 2022

Otoniel shipped ‘outrageous’ amounts of cocaine to US: Prosecutor

Accused Colombian drug trafficker pleads not guilty to two charges after being extradited to the US from Bogota.

Al Jazeera · May 5, 2022

The trouble with telehealth prescriptions

Cerebral told clinicians it will stop prescribing Adderall and other controlled substances to treat ADHD for new patients.

Axios · May 5, 2022

'DEA Has Blown It Again' - MMJ Request Federal Court Action For Emergency Motion To Expedite

Megan Sheehan of Sheehan & Associates, Attorneys representing MMJ International Holdings and MMJ BioPharma Cultivation etal, scheduled to execute on clinical trials in Huntington's disease and multiple sclerosis, filed a motion in federal court against the Drug Enforcement Administration, asking the federal court for "an emergency motion for irrepa

Benzinga · May 5, 2022